Details of issuance or disposal
Issuance of Euro-Yen Convertible Bonds with Stock Acquisition Rights Subject to Acquisition Clauses, Due 2031 and Due 2033
2031 bonds: ¥5 billion plus the aggregate face amount of the bonds relating to substitute bonds with stock acquisition rights; 2033 bonds: ¥5 billion plus the aggregate face amount of the bonds relating to substitute bonds with stock acquisition rights
5.32% (ratio of potential shares to the total number of issued shares outstanding, excluding treasury shares, as of 18 September 2026, assuming that all stock acquisition rights attached to both bonds are exercised at the initial conversion prices)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of Euro-Yen Convertible Bonds with Stock Acquisition Rights Subject to Acquisition Clauses, Due 2031 and Due 2033 |
| Total issue value | 2031 bonds: ¥5 billion plus the aggregate face amount of the bonds relating to substitute bonds with stock acquisition rights; 2033 bonds: ¥5 billion plus the aggregate face amount of the bonds relating to substitute bonds with stock acquisition rights |
| Payment date | 13 October 2026 (London time) |
| Dilution Rate | 5.32% (ratio of potential shares to the total number of issued shares outstanding, excluding treasury shares, as of 18 September 2026, assuming that all stock acquisition rights attached to both bonds are exercised at the initial conversion prices) |
| Basis for determining the amount to be paid | 2031 bonds: conversion price of ¥2,845, representing a 21.04% premium to the closing price of ¥2,350.5 on 24 September 2026. 2033 bonds: conversion price of ¥2,704, representing a 15.04% premium to the same closing price. |
| Exercise price | Conversion price: ¥2,845 for the 2031 bonds and ¥2,704 for the 2033 bonds. Whether an adjustment provision applies and the adjustment floor: Not disclosed |
| Exercise period | 2031 bonds: from 27 October 2026 through 24 September 2031. 2033 bonds: from 27 October 2026 through 26 September 2033 (in each case, based on the local time at the location where exercise requests are accepted; subject to restrictions such as early redemption) |
Items this document does not state (21)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The issue terms and other matters were determined for the issuance already approved by the Board of Directors at its meeting held on 24 September 2026.